Yl Proiect ORIGINAL: English COUNTRYAIOTF:NIGERIA I\Ame: NO'rr'7whu APUC OYO STATE CDTI PROJECT
Total Page:16
File Type:pdf, Size:1020Kb
Oyo Stat Yl Proiect ORIGINAL: English COUNTRYAIOTF:NIGERIA I\ame: NO'rr'7wHU APUC OYO STATE CDTI PROJECT Approval yearz 1999 Launchine year: 1999 Renortinq Period: From: January 2006 To: December 2006 (Month/YearTth) ( Month/Year) Proiect vear of this report: (circleone) I 2 3 4 5 6(7) S 9 10 Date submitted NGDO partner: TINICEF I I I I I I I I I I I I I AhINUAL PROJECT TECHNICAL REPORT I I SUBMITTED TO I I TECHNICAL CONSULTATIVE COMMITTEE (TCC) I I I ENDORSEMENT I I I I I I I DEADLINE I FOR SUBMISSION: I I To APOC Management by 3l January for March TCC meeting To APOC Management by 31 Julv for September TCC meeting AFRICAN PROGRAMME FOR ONCHOCERCIASIS CONTROL (APOC) tlz To: -ikcls cev aiH I cs! Alt€ EFo tb For lil;ir;;iion ro,!iR. I 0 I JU|N 2007 I Aon t An/rtl3l t , E I H. Batr'.eno- I I I I I I ANI\UAL PROJECT TECHNICAL REPORT TO TECHNICAL CONSULTATIVE COMMITTEE (TCC) ENDORSEMENT Please confirm you have read this report by signing in the appropriate space. OFFICERS to sign the rePort: Country: NIGERIA National Coordinator Name: .Mrs.lOgbu-Pearce Signature: @*r.*-... Date: . z;f PeI2-? T.-J- Zonal Oncho Coordinator Name: ...Otunba Adekunle Jaiyeoba fr49*cl^?xD} NGDORepresentative Name Signature: Date: . This report was prepared by Name : ......Mrs. J.A. Aliyu Designation : State rrrl:":r*. Signature , ..u.Al@tt Date ../..7..:..11*.c.l: .. *2*o? I ,l WHO/APOC, 24 November 2004 Table of contents ACRONYMS V DEFINITIONS........ VI FOLLOW UP ON TCC RECOMMENDATIONS I EXECUTIVE SUMMARY 2 SECTION I : BACKGROT ND INFORMATION....... 3 I.1. GENERAL INFORMATION J l.l.l Description of the project (briefly) ...... ,3 1.1.2 Partnership .3 I.2. POPULATION. 4 SECTION 2 : IMPLEMENTATION OF CDTI. 5 2.1 TTMELINE oF ACTrvtrrvrES......... 5 2.2 ADVoCACY ,7 2.3 MoBILIZATIoN, SENSITIZATIoN AND HEALTH EDUCATIoN oF AT RISK coMMUNITIES .... ..7 2.4 coMMUNrry INVoLVEMENT ........... 8 2.5 CAPACITY BUILDING .9 2.6 TREATMENTS............... lt 2.6.1. Treatment flgures......... .l I 2.6.2. What are the causes of absenteeism? ............... l3 2.6.3. What are the reasons for refusals? l3 2.6.4. Briefly describe all known and verified serious advserve events (SAEs) that...... l3 2.6.5. Trend of treatment achievement from CDTI project inception to the current year l5 2.7. ORDERING, STORAGE AND DELIVERY OF IVERMECTIN l6 2.8, COMMUNITY SELF-MONITORING AND STAKEHOLDERS MEETING......... l6 2.9. SUPERVISrON .............. l7 2.9.1. Provide a flow chart ofsupervision hierarchy...... t7 2.9.2. What were the main issues identified during supervision ?.......... l7 2.9.3. Was a supervision checklist used?.......... t7 2.9.4. What were the outcomes at each level of CDTI implementation supervision ?..,, l7 2.9.5. Was feedback given to the person or groups supervised? t7 2.9.6. How was the feedback used to improve the overall performance of the project... l7 SECTION 3 : SUPPORT TO CDTI 3.1. EQUrPMENT........... ... 17 3.2. FINANCIAL CONTRIBUTIONS OF THE PARTNERS AND COMMLINITIES........ .. l8 3.3. OTHER FORMS OF COMMUNITY SUPPORT. .. 18 3.4. EXPENDITURE PER ACTIVITY ................. ... l8 SECTION 4: SUSTAINABILITY OF CDTI......... .. 19 4.I. INTERNAL;INDEPENDENT PARTICIPATORY MONITORING;EVALUATIoN .t9 4.1 ' I Was Monitoring/evaluation carried out during the report period? (tick any of the following Which are applicable).... l9 4. 1.2. What were the recommendations ?.......... .................. l9 4.1.3. How have they been implemented?........... lg 4.2. SUSTAINABILITY oF PROJECTS: PLAN AND sET TARGETS (MANDATORY AT.. 20 YEAR 3)............ .....20 4.2.1. Planning at all relevant Ieve|s.......... .....20 4.2.2. Funds.......... ....20 4.2.3. Transport (replacement and maintenance)............. .....20 4.2.4. Other resources .............. ....20 4.2.5. To what extent has the plan been implemented ....... ...20 4.3. INTEGRATION..... .20 4.3.1. Ivermectin deliverymechanisms.. ..20 4.3.2. Training....... ,,.20 4.3.3. Joint supervision and monitoring with other programs ,,.20 4 4.3.4. Release of funds for project activities...... ..20 4.3.5. Is CDTI included in the PHC budget? ,20 4.3.6. Describe other health programmes that are using the CDTI structure and how this was Achieved. What have been the achievements? ..20 4.3.7 Describe others issues considered in the integration of CDTI... 20 4.4.OPERATIONAL RESEARCH 20 4.4.1. Summarize in not more than one half of a page the operational research Undertaken in the project area within the reporting period......... 20 4.4.2. How were the results applied in the project? 20 SECTION 5: STRENGTH, WEAKNESSES, CHALLENGE, AND OPPORTUNITIES.... 2t SECTION 6: UNIQUE FEATURES oF THB PROJECT/OrHER MATTERS ..21 3 Acronyms AIDS Acquired Immune Deficiency Syndrome APOC African Programme for Onchocerciasis Control ATO Annual Treatment Obj ective AtrO Annual Training Objective CDA Community Development Association CDD Community-Directed Distributor CDI Community Directed Intervention CDTI Community-Directed Treatment with Ivermectin CBO Community-Based Organ ization CSM Community Self-Monitoring DOTS Directly Observed Treatment Short-course DSN Disease Surveillance & Notifi cation FHFS First Line Health Facility HFS Health Faciliry Staff HMM Home Management of Malaria HQ Headquarters HIV Human Immuno Deficiency Virus IEC Information Education and Communication IFESH International Foundation for Education and Self Help ITN Insecticide Treated Net LG LocalGovemment LGA Local Government Area LOCT Local Government Oncho Control Team MDP Mectizan Donation Program MOH Ministry of Health NOCP National Onchocerciasis Control Programme NOTF National Onchocerciasis Task Force NGDO Non-Governmental Development Organization NGO Non-Governmental Organ ization NPI National Programme on Immunization NURTW National Union of Road Transport Workers PHC Primary health care RBM RollBack Malaria REMO Rapid Epidemiological Mapping of Onchocerciasis SAE Severe adverse event SOCT State Oncho Control Team SHM Stakeholders meeting TCC Technical Consultative Committee (APOC scientific advisory group) TOT Trainer of trainers TV Television UNICEF United Nations Children's Fund UTG Ultimate Treatment Goal wHo World Health Organ ization ZOTF Zonal Task Force + Definitions (i) Total ation: the total population living in meso/hyper-endemic communities within the project area (based on REMO and census taking). (ii) Eligible population: calculated as 84Yo of the total population in meso4ryper- endemic communities in the project area. (iii) Annual Treatment Objective: (ATO): the estimated number of persons living in meso/hyper-endemic areas that a CDTI project intends to treat with ivermectin in a given year. (iv) Ultimate Treatment Goal (UTG): calculated as the maximum number of people to be treated annually in meso/hyper endemic areas within the project area, ultimately to be reached when the project has reached full geographic coverage (normally the project should be expected to reach the UTG at the end of the 3d year ofthe project). (v) Therapeutic coverage: number of people treated in a given year over the total population (this should be expressed as a percentage). (vi) Geographical covera&e: number of communities treated in a given year over the total number of meso/hyper-endemic communities as identified by REMO in the project area (this should be expressed as a percentage). (vii) lntegration: delivering additional health interventions (i.e. vitamin A supplements, albendazole for LF, screening for cataract, etc.) through CDTI (using the same systems, training, supervision and personnel) in order to maximise cost- effectiveness and empower communities to solve more of their health problems. This does not include activities or interventions carried out by community distributors outside of CDTL (viii) Sustainabilit),: CDTI activities in an area are sustainable when they continue to function effectively for the foreseeable future, with high treatment coverage, integrated into the available healthcare service, with strong community ownership, using resources mobilised by the community and the govemment. (ix) community self-monitoring (cSM): The process by which the community is empowered to oversee and monitor the performance of GDTI (or any community- based health intervention programme), with a view to ensuring that the programme is being executed in the way intended. It encourages the community io tat" futt responsibility of ivermectin distribution and make appropriate modifrcations when necessary. 5 FOLLOW UP ON TGG REGOMMENDATIOI{S Using the table below, fill in the recommendations of the last TCC on the project and describe how they have been addressed. TCC session 20- Number of TCC ACTIONS TAKEN BY THE FOR Recommendafion RECOMMENDATIONS PROJECT TCC/APOC in the Reporl MGT USE ONLY Train more CDDs per 1368 CDDs were trained in 2005, but in Community 2006 I,900 new CDDs were trained. The State is part of a special country initiative approved by APOC which targets increased number of CDDs, health workers and community supervisors. 5,700 CDDs are expected to be trained/ retrained. This will be carried out in 2007. Train more health 460 health staff were trained in 2005, workers to raise the no. of and 485 health workers were trained or health workers involved retrained in 2006. Under the special in CDTI initiative 560 health workers are expected to be trained in2007. Target those LGAs with The LGAs with low coverage are being consistently low coverage followed up. atea lmplement CSM/SHM in Not much was done in2006 as a follow all the LGAs in a clearly up to what had been carried out in 2005. defined phase in all the With the special initiative coming up it community is expected that the pace on CSM/SHM implementation will be quickened. About 4,600 community supervisors will be trained. These will be utilized to lm lement CSM. Report on the Additional follow up actions taken in sustainability evaluation the course ofthe year are reflected in results in the next report the appropriate section.